ProfileGDS4132 / 205096_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 79% 79% 55% 53% 77% 77% 69% 79% 52% 57% 46% 40% 45% 41% 39% 37% 50% 39% 39% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101263.13379
GSM201543Muscle PCOS pioglitazone 121249.05479
GSM201544Muscle PCOS pioglitazone 161152.46355
GSM201545Muscle PCOS pioglitazone 201153.97453
GSM201829Muscle PCOS pioglitazone 231262.68277
GSM201830Muscle PCOS pioglitazon 251258.57977
GSM201831Muscle PCOS pioglitazone 271210.60169
GSM201832Muscle PCOS pioglitazone 31255.21679
GSM201833Muscle PCOS pioglitazone 41130.77652
GSM201834Muscle PCOS pioglitazone 81154.86957
GSM201835Muscle PCOS after pioglitazone 102106.70346
GSM201836Muscle PCOS after pioglitazone 12291.624340
GSM201837Muscle PCOS after pioglitazone 162102.61345
GSM201838Muscle PCOS after pioglitazone 20296.395741
GSM201839Muscle PCOS after pioglitazone 23292.756239
GSM201840Muscle PCOS after pioglitazone 25290.059237
GSM201841Muscle PCOS after pioglitazone 272119.39150
GSM201842Muscle PCOS after pioglitazone 3281.940539
GSM201843Muscle PCOS after pioglitazone 4297.318339
GSM201844Muscle PCOS after pioglitazone 82103.53742